SCHEMBL1637610

SCHEMBL1637610

CCCN(CCC)Cc1ccc(CN(C)Cc2ccc(CNC(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
GAA P10253 1/20 0.43
RORC P51449 2/20 0.42
HRH3 Q9Y5N1 1/20 0.42
AKT1 P31749 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
SDCBP O00560 1/20 0.40
SDC2 P34741 1/20 0.40
CTSK P43235 1/20 0.40
HDAC1 Q13547 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
MAPT P10636 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206601 0.89 NAMPT (0.43) NAMPTL3MBTL1GAAAKT1CA1
SCHEMBL1638678 0.85 L3MBTL1 (0.43) NAMPTL3MBTL1GAARORCCA1
SCHEMBL1205947 0.84 NAMPT (0.58) NAMPTL3MBTL1RORCHDAC1MAPT
SCHEMBL1637283 0.83 DRD2 (0.40) NAMPTL3MBTL1GAARORCCA1
SCHEMBL28177091 0.82 L3MBTL1 (0.46) NAMPTL3MBTL1GAAAKT1CA1
SCHEMBL1636536 0.82 DRD2 (0.40) NAMPTL3MBTL1GAARORCCA1
SCHEMBL23775214 0.81 LSS (0.52) NAMPTL3MBTL1GAAAKT1CA1
SCHEMBL1638183 0.80 DRD2 (0.39) NAMPTL3MBTL1GAARORCAKT1
SCHEMBL1638611 0.79 CA1 (0.43) L3MBTL1GAARORCCA1CA2
SCHEMBL3180689 0.79 L3MBTL1 (0.61) NAMPTL3MBTL1GAACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724263-B1 BASIC AMINE COMPOUND AND USE THEREOF KUREHA CORP (JP) 2014-03-05 EP disclosed
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF KUREHA CORPORATION (JP) 2011-07-14 US disclosed
US-7932281-B2 Amine-based compound and use thereof KUREHA CORPORATION (JP) 2011-04-26 US disclosed
US-20070208007-A1 Amine-Based Compound and Use Thereof KUREHA CORPORATION (JP) 2007-09-06 US disclosed
EP-1724263-A1 BASIC AMINE COMPOUND AND USE THEREOF Kureha Corporation (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF NR0B2, NR5A2, NR1D2 NAMPT 2707/4885L3MBTL1 884/4885GAA 4793/4885
US-20070208007-A1 Amine-Based Compound and Use Thereof NR0B2, NR5A2, NR2E1 NAMPT 2306/4885L3MBTL1 1179/4885GAA 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.